Ciatto S, Catarzi S, Morrone D, Del Turco M R
Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy.
Radiology. 1993 Jul;188(1):195-8. doi: 10.1148/radiology.188.1.8511296.
The authors evaluated ultrasound (US)-guided fine-needle aspiration cytology (FNAC) in 270 patients with suspicious findings at mammography. FNAC with a 10-MHz transducer and real-time scanner was performed when a lesion seen mammographically was unequivocally depicted at US. The needle was inserted with variable obliquity to the scanning plane. Stereotaxically guided FNAC was performed when lesions were not visible at US. High suspicion at mammography and positive cytologic reports led to surgical biopsy. Of the 270 lesions, 120 (44.4%) were visible at US. Opacities were the most frequently visualized lesions. Inadequate samplings were most frequently reported for opacities with smooth margins. Differences in accuracy and inadequacy rate between the two modalities were not significant. Cancer was surgically confirmed in 86 of 110 cases. The other 160 lesions were considered benign, and mammographic follow-up in 120 has shown no change. Because FNAC with US guidance was faster and less expensive, it is recommended as the technique of choice in lesions detectable with US.
作者对270例乳腺钼靶检查有可疑发现的患者进行了超声(US)引导下细针穿刺细胞学检查(FNAC)。当钼靶检查所见病变在超声下能明确显示时,使用10兆赫探头和实时扫描仪进行FNAC。针以与扫描平面不同的倾斜度插入。当病变在超声下不可见时,进行立体定向引导下的FNAC。乳腺钼靶高度可疑及细胞学报告阳性导致手术活检。在这270个病变中,120个(44.4%)在超声下可见。不透明影是最常观察到的病变。边缘光滑的不透明影最常报告采样不足。两种检查方式在准确性和采样不足率方面的差异不显著。110例中有86例手术确诊为癌症。其他160个病变被认为是良性的,120例的乳腺钼靶随访显示无变化。由于超声引导下的FNAC更快且成本更低,对于超声可检测到的病变,推荐将其作为首选技术。